Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
Location status: Recruiting
Location contact
Dana Carroll, PhD, MPH
CONTACT
NCT Number: NCT06544811
The aim of this clinical trial is to test the efficacy of a culturally aligned digital smoking cessation resource for American Indian persons who smoke, via a remotely conducted randomized controlled trial.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Minneapolis, Minnesota, 55455, United States
Location status: Recruiting
Dana Carroll, PhD, MPH
CONTACT
This is a two-arm, parallel group, randomized controlled clinical trial. Eligible participants (n=416) will be randomized to either the culturally aligned resource or the general audience version. Participants will use the assigned resource for 6 months, and partake in surveys at baseline, and 1, 3 and 6 months, during which they will be asked several questions related to use of their assigned resource, and smoking behavior. Carbon monoxide (CO) in exhaled breath will be collected at 1, 3 and 6 months using iCO™ Smokerlyzer® (https://www.icoquit.com/us/).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A free text message smoking cessation program that provides 24/7 encouragement, advice, and tips to those trying to quit smoking.
A free text message smoking cessation program that provides 24/7 encouragement, advice, and tips to those trying to quit smoking and has been developed for American Indian and Alaska Native persons.
Time frame: 6 months
Percent of participants that are biochemically confirmed 7-day abstinence from all combustible tobacco products (defined as self-reported abstinence during the past seven days [not even a puff of cigarettes, cigars, hookah, or pipe tobacco] with a negative breath CO test ≤ 4 ppm).
Time frame: 1 and 3 months
Percent of participants that are biochemically-confirmed 7-day abstinence at 1, 3 months
Time frame: 1, 3, and 6 months
Percent of participants that self-report 24-hour abstinence at 1, 3, and 6 months
Time frame: 1, 3, and 6 months
Percent of participants that self-report 7-day abstinence at 1, 3, and 6 months
Time frame: 3 and 6 months
Percent of participants that self-report 30-day abstinence at 3 and 6 months
Time frame: 1, 3, and 6 months
Change in mean cigarettes per day in past 7 days at 1, 3, and 6 months
Time frame: 1, 3, and 6 months
Number of 24-hour quit attempts in past 30 days at 1, 3, and 6 months
Time frame: 1, 3, and 6 months
Percent of participants that used nicotine replacement therapy and pharmacotherapy (e.g.
nicotine patch, Chantix) in past 30 days at 1, 3, and 6 months
Time frame: 1, 3, and 6 months
Percent of participants that used other behavioral support (e.g. in-person, quitline) for smoking cessation in past 30 days at 1, 3, and 6 months
Time frame: 1, 3, and 6 months
Percent of participants that used other commercial tobacco products (e.g., smokeless tobacco, e-cigarettes) in the past 7 days 1, 3, and 6 months
Time frame: 1, 3, and 6 months
mean cigarette dependence at 1, 3, and 6 months
Contact information is provided by the study sponsor or research team.
Masonic Cancer Center, University of Minnesota
Other
Randomized Clinical Trial of A Culturally Aligned Digital Smoking Cessation Resource for American Indian Persons
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07585357
Behavior, Health Behavior
Baltimore, Maryland, United States
View Trial DetailsNCT06584929
Behavior, Health Behavior
Minneapolis, Minnesota, United States
View Trial DetailsNCT07166120
Behavior, Health Behavior
St Louis, Missouri, United States
View Trial DetailsNCT06651684
Behavior, Chemically-Induced Disorders
Montreal, Quebec, Canada
View Trial Details